Long-term Monitoring of Growth and Development of Pediatric Patients Previously Treated With Everolimus

NCT02338609 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Growth and Development

Interventions

DRUG: Everolimus

Sponsor

Novartis Pharmaceuticals